Compile Data Set for Download or QSAR
Report error Found 28 Enz. Inhib. hit(s) with all data for entry = 7912
TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398094BDBM50398094(CHEMBL2182044 | US9321738, 11)
Affinity DataIC50: 18nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398093BDBM50398093(CHEMBL2182046 | US9321738, 6)
Affinity DataIC50: 18nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398095BDBM50398095(CHEMBL2182043 | US9321738, 2)
Affinity DataIC50: 18nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398091BDBM50398091(CHEMBL2182049 | US9321738, 12)
Affinity DataIC50: 18.8nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398090BDBM50398090(CHEMBL2182050 | US9321738, 13)
Affinity DataIC50: 24.5nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 223530BDBM223530(US9321738, 4)
Affinity DataIC50: 46nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398096BDBM50398096(CHEMBL2182042 | US9321738, 3)
Affinity DataIC50: 48nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398089BDBM50398089(CHEMBL2182051 | US9321738, 14)
Affinity DataIC50: 58nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398090BDBM50398090(CHEMBL2182050 | US9321738, 13)
Affinity DataIC50: 65.7nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398112BDBM50398112(CHEMBL2182045 | US9321738, 7)
Affinity DataIC50: 70nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398093BDBM50398093(CHEMBL2182046 | US9321738, 6)
Affinity DataIC50: 132nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 223530BDBM223530(US9321738, 4)
Affinity DataIC50: 279nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398095BDBM50398095(CHEMBL2182043 | US9321738, 2)
Affinity DataIC50: 2.29E+3nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398091BDBM50398091(CHEMBL2182049 | US9321738, 12)
Affinity DataIC50: 2.31E+3nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398092BDBM50398092(CHEMBL2182047 | US9321738, 5)
Affinity DataIC50: 2.66E+3nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 223532BDBM223532(US9321738, 9)
Affinity DataIC50: 4.45E+3nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398092BDBM50398092(CHEMBL2182047 | US9321738, 5)
Affinity DataIC50: 6.31E+3nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 223532BDBM223532(US9321738, 9)
Affinity DataIC50: 1.84E+4nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398089BDBM50398089(CHEMBL2182051 | US9321738, 14)
Affinity DataIC50: 1.86E+4nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 223529BDBM223529(US9321738, 1)
Affinity DataIC50: 2.19E+4nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398096BDBM50398096(CHEMBL2182042 | US9321738, 3)
Affinity DataIC50: 2.19E+4nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398094BDBM50398094(CHEMBL2182044 | US9321738, 11)
Affinity DataIC50: 2.74E+4nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 223529BDBM223529(US9321738, 1)
Affinity DataIC50: 3.00E+4nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 223533BDBM223533(US9321738, 10)
Affinity DataIC50: 3.00E+4nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 223531BDBM223531(US9321738, 8)
Affinity DataIC50: 3.00E+4nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 50398112BDBM50398112(CHEMBL2182045 | US9321738, 7)
Affinity DataIC50: 3.00E+4nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 1(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 223531BDBM223531(US9321738, 8)
Affinity DataIC50: 3.00E+4nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent

TargetLysophosphatidic acid receptor 3(Human)
Hoffmann-La Roche

US Patent
LigandChemical structure of BindingDB Monomer ID 223533BDBM223533(US9321738, 10)
Affinity DataIC50: 3.00E+4nMT: 2°CAssay Description:Test compounds were prepared by adding 90 μL of HBSS/20 mM HEPES/0.1% BSA buffer to 2 μL of serially diluted compounds. To prepare serial dilut...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/1/2017
Entry Details
US Patent